POLR3GL

POLR3GL encodes RPC7β, one of two mutually exclusive alternative subunits that define distinct isoforms of RNA polymerase III in vertebrates, the other being the paralog POLR3G (RPC7α) which arose from the same ancestral DNA-based gene duplication (PMID:24107381, PMID:34850129). POLR3GL- and POLR3G-containing Pol III complexes occupy the same target genes in constant proportions and perform the same core transcriptional function in vitro and in vivo, but the two isoforms acquired distinct regulation and differential output: the POLR3GL promoter does not bind MYC, and POLR3GL-containing Pol III displays reduced transcriptional activity at a subset of targets — notably the snaR-A noncoding RNA — relative to the more active POLR3G isoform, a difference linked to RPC7 C-terminal domain architecture (PMID:24107381, PMID:35637192, PMID:34850129). This isoform composition acts as a regulatory determinant of cell fate: POLR3GL is upregulated during differentiation (including Xenopus skeletal myogenesis) while POLR3G predominates in proliferating cells, and the two subunits influence the synthesis of specific tRNA isoacceptors (PMID:31173763, PMID:35637192). The subunits functionally compensate in vivo — exogenous POLR3GL rescues the differentiation defect of POLR3G-knockout ESCs — but compensation is constrained by total Pol III levels, since POLR3GL-knockout mice complete embryogenesis yet die ~3 weeks after birth with growth and cerebellar defects attributed to insufficient total Pol III rather than a unique POLR3GL function (PMID:32576691). Biallelic loss-of-function variants in POLR3GL cause Pol III-related developmental disorders, including endosteal hyperostosis with oligodontia and a neonatal progeroid syndrome variant (PMID:31089205, PMID:31695177).

1. 2013 High

   Established whether the two RPC7 paralogs build functionally divergent Pol III complexes or merely differ in their own regulation, by mapping where each isoform binds genome-wide.

   Evidence Genome-wide ChIP-seq, evolutionary genomic analysis, and promoter-MYC binding analysis in a cell line

   PMID:24107381

   Open questions at the time

   • Same occupancy does not establish equal transcriptional output at occupied genes
   • MYC absence at the POLR3GL promoter not linked to a downstream functional consequence
   • Tested in a single cell line
2. 2019 Medium

   Showed POLR3GL and POLR3G are not interchangeable in cell-fate control, since depleting each subunit produced opposite phenotypic consequences in cancer cells.

   Evidence siRNA depletion with proliferation/differentiation readouts in prostate cancer lines

   PMID:30820548

   Open questions at the time

   • Mechanism linking POLR3GL depletion to its lack of phenotype unresolved
   • Knockdown not whole-organism; single lineage
3. 2019 Medium

   Linked Pol III isoform identity to tRNA output and differentiation by showing reciprocal expression and distinct tRNA isoacceptor activities of the two subunits during myogenesis.

   Evidence Custom tRNA microarray and overexpression rescue in Xenopus myogenic differentiation

   PMID:31173763

   Open questions at the time

   • Specific tRNA isoacceptors driving the fate switch not pinned to phenotype
   • Ortholog system; mammalian generalization untested here
4. 2019 Medium

   Established POLR3GL as a disease-causing Pol III subunit by tying biallelic loss-of-function to endosteal hyperostosis and oligodontia with transcript-level confirmation.

   Evidence Whole exome and RNA sequencing validating splice-acceptor loss-of-function in patients

   PMID:31089205

   Open questions at the time

   • Molecular path from Pol III deficiency to bone/dental phenotype not defined
   • Single study cohort
5. 2019 Medium

   Broadened the POLR3GL disease spectrum by linking a homozygous nonsense allele undergoing NMD to a neonatal progeroid syndrome variant.

   Evidence Exome sequencing with RNA-level NMD confirmation in a patient

   PMID:31695177

   Open questions at the time

   • Single case report
   • Mechanism connecting null allele to progeroid features unknown
6. 2020 High

   Resolved whether POLR3GL has a unique essential function or acts as a quantitative contributor to Pol III, using knockout mice and ESC rescue.

   Evidence Conditional/constitutive knockout mice, in vitro transcription, ChIP-seq, and ESC differentiation rescue

   PMID:32576691

   Open questions at the time

   • Why postnatal lethality occurs despite completed embryogenesis not fully explained
   • Cerebellar neuronal defect described as potential, not mechanistically dissected
7. 2022 High

   Defined the functional asymmetry between the isoforms by showing POLR3G loss restricts the Pol III repertoire (especially snaR-A) while POLR3GL loss does not, marking isoform identity as a transcriptional regulatory mechanism.

   Evidence POLR3G knockout/depletion with ChIP-seq, RNA-seq, and isoform occupancy genomics

   PMID:35637192

   Open questions at the time

   • Structural basis for reduced POLR3GL activity not directly tested here
   • Physiological role of snaR-A sensitivity unresolved
8. 2021 Medium

   Synthesized structural and genomic evidence attributing the reduced activity of the POLR3GL (RPC7β) isoform to C-terminal domain differences between the two alternate subunits.

   Evidence Review integrating cryo-EM structures and ChIP-seq data from multiple labs

   PMID:34850129

   Open questions at the time

   • Causal link between C-terminal architecture and activity not demonstrated by direct mutagenesis here
   • Review-level synthesis rather than primary data

• It remains unknown how the POLR3GL-specific reduction in Pol III activity at targets like snaR-A is converted into the tissue-specific developmental phenotypes of bone, teeth, and progeroid disease.
• No direct mechanistic chain from isoform-specific transcript changes to organ phenotypes
• C-terminal domain function not tested by targeted mutation in vivo
• Tissue specificity of compensation by POLR3G not mapped